147 related articles for article (PubMed ID: 20712462)
1. Usefulness of droperidol as an anti-emetic in terminally ill cancer patients.
Thangathurai D; Roffey P
J Palliat Med; 2010 Aug; 13(8):939. PubMed ID: 20712462
[No Abstract] [Full Text] [Related]
2. Results of antiemetic management in terminal illness.
Lichter I
J Palliat Care; 1993; 9(2):19-21. PubMed ID: 8397302
[TBL] [Abstract][Full Text] [Related]
3. Drug treatment of adults with nausea and vomiting in primary care.
Furyk JS; Meek R; McKenzie S
BMJ; 2014 Aug; 349():g4714. PubMed ID: 25103458
[No Abstract] [Full Text] [Related]
4. Droperidol for treatment of nausea and vomiting in palliative care patients.
Dorman S; Perkins P
Cochrane Database Syst Rev; 2010 Oct; (10):CD006938. PubMed ID: 20927752
[TBL] [Abstract][Full Text] [Related]
5. Postoperative nausea and vomiting in children.
Baines D
Paediatr Anaesth; 1996; 6(1):7-14. PubMed ID: 8839082
[No Abstract] [Full Text] [Related]
6. [The use of navoban in the therapy of oncology patients with highly emetic treatments].
Russel AJ
Vopr Onkol; 1995; 41(1):87-90. PubMed ID: 7667952
[No Abstract] [Full Text] [Related]
7. Droperidol for treatment of nausea and vomiting in palliative care patients.
Storrar J; Hitchens M; Platt T; Dorman S
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006938. PubMed ID: 25429434
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of postoperative nausea and vomiting to determine antiemetic activity of droperidol added to propofol: a possible drug interaction.
Wagner BK; Berman SL; Devitt PA; O'Hara DA
Pharmacotherapy; 1994; 14(5):586-91. PubMed ID: 7997392
[TBL] [Abstract][Full Text] [Related]
9. Symptom control in geriatric patients with terminal cancer: pain, nausea, and vomiting.
Kinzel T
Geriatrics; 1988 Jun; 43(6):83-4, 87-9. PubMed ID: 3366386
[TBL] [Abstract][Full Text] [Related]
10. Torsade de Pointes after administration of droperidol for nausea and vomiting.
Choo EK; Weber FS; Schmidt TA
Prehosp Emerg Care; 2009; 13(2):261-5. PubMed ID: 19291568
[TBL] [Abstract][Full Text] [Related]
11. The management of nausea and vomiting.
Sykes N
Practitioner; 1990 Mar; 234(1485):286-90. PubMed ID: 2284268
[No Abstract] [Full Text] [Related]
12. Management of nausea and vomiting in the cancer patient.
Frytak S; Moertel CG
JAMA; 1981 Jan 23-30; 245(4):393-6. PubMed ID: 7452866
[No Abstract] [Full Text] [Related]
13. [Treatment and prevention of nausea and vomiting during spinal block-effects of droperidol].
Yasunaka H; Kimura Y; Goto T; Saito F
Masui; 1974 Nov; 23(12):1253-5. PubMed ID: 4477616
[No Abstract] [Full Text] [Related]
14. Nausea and vomiting in advanced cancer.
Harris DG
Br Med Bull; 2010; 96():175-85. PubMed ID: 20884654
[TBL] [Abstract][Full Text] [Related]
15. Anti-emetic efficacy of prophylactic granisetron, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial.
Fujii Y; Saitoh Y; Tanaka H; Toyooka H
Eur J Anaesthesiol; 1998 Mar; 15(2):166-71. PubMed ID: 9587723
[TBL] [Abstract][Full Text] [Related]
16. Management of nausea and vomiting.
Enck RE; Hogan CM
Am J Hosp Care; 1987; 4(4):17-9. PubMed ID: 3649245
[No Abstract] [Full Text] [Related]
17. Chlorpromazine, placebo and droperidol in the treatment of nausea and vomiting associated with cisplatin therapy.
Stuart-Harris R; Buckman R; Starke I; Wiltshaw E
Postgrad Med J; 1983 Aug; 59(694):500-3. PubMed ID: 6353396
[TBL] [Abstract][Full Text] [Related]
18. Nausea and vomiting in the patient with advanced cancer: an overview of pharmacological and non-pharmacological management.
McVey P
Collegian; 2001 Apr; 8(2):41-2. PubMed ID: 15484623
[No Abstract] [Full Text] [Related]
19. First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.
Goldsmith B
Acta Oncol; 2004 Sep; 43 Suppl 15():19-22. PubMed ID: 15370626
[No Abstract] [Full Text] [Related]
20. Antiemetic therapy for nausea and vomiting in the emergency department.
Patanwala AE; Amini R; Hays DP; Rosen P
J Emerg Med; 2010 Sep; 39(3):330-6. PubMed ID: 20022195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
